secwatch.observer — SEC 8-K summary
======================================

Issuer:     MoonLake Immunotherapeutics (MLTX)
CIK:        0001821586
Form:       8-K
Filed at:   2025-11-05T23:59:59+00:00
Accession:  0001213900-25-106723
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MoonLake Immunotherapeutics raises $75M in equity offering of 7.1M shares at $10.50/share
--------------------------------------------------------------------------------

- Offering of 7,142,857 Class A ordinary shares at $10.50 per share for gross proceeds of $75M.
- Underwriting agreement with Leerink Partners LLC; expected close on November 6, 2025.
- Shares offered under existing shelf registration statement on Form S-3 (File No. 333-274286).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1821586/000121390025106723/0001213900-25-106723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1821586/000121390025106723/ea0264149-8k_moonlake.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-106723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer